A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Tam, Constantine S; Opat, Stephen; D’Sa, Shirley; et al; Dimopoulos, Meletios; (16/33) Fernandez de Larrea, Carlos. 2020. A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstrom macroglobulinemia: the ASPEN study.Blood. 136-18, pp.2038-2050. ISSN 1528-0020. WOS (120)
The American Society of Hematology